Gastrointestinal Disorders Following Initiation of Dolutegravir, Elvitegravir, Raltegravir or Darunavir

Posted on December 14, 2022 by -

Mounzer K, Brunet L, Fusco J, et al. Gastrointestinal Disorders Following Initiation of Dolutegravir, Elvitegravir, Raltegravir or Darunavir. Presented at: 10th IAS Conference on HIV Science 2019; Mexico City, Mexico

<Download PDF>